Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application

Veterinary Journal

Volumn 194, Issue 2, 2012, Pages 151-157

  Chae, Chanhee ^a  

^a Seoul National University   (South Korea)

Author keywords

Porcine circovirus type 2; Porcine circovirus associated disease; Postweaning multisystemic wasting syndrome; Vaccine

Indexed keywords

CIRCOFLEX; CIRCOVAC; CIRCUMVENT; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; PORCILLIS PCV; PORCINE CIRCOVIRUS TYPE 2 VACCINE; SUVAXYN PCV2 ONE DOSE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL WELFARE; ANTIBODY TITER; CELLULAR IMMUNITY; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CLINICAL EXAMINATION; CLINICAL FEATURE; CROSS PROTECTION; CYTOKINE RELEASE; DRUG APPROVAL; DRUG EFFICACY; FEMALE INFERTILITY; HISTOPATHOLOGY; IMMUNE RESPONSE; INFECTION CONTROL; MORTALITY; MULTIPLE DRUG DOSE; NONHUMAN; OPEN READING FRAME; PIGLET; PORCINE CIRCOVIRUS ASSOCIATED DISEASE; PORCINE CIRCOVIRUS TYPE 2; PORCINE RESPIRATORY DISEASE COMPLEX; POSTWEANING MULTISYSTEMIC WASTING SYNDROME; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; SOW (SWINE); SWINE; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CANADA; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; FEMALE; FRANCE; GERMANY; MALE; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; SEMEN; SWINE; SWINE DISEASES; VIRAL VACCINES; VIRUS SHEDDING;

PORCINE CIRCOVIRUS; PORCINE CIRCOVIRUS 2; SUIDAE;

EID: 84868695915     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.06.031     Document Type: Review

References (63)

1. Alberti K.A., Estienne M.J., Meng X.J. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding. Journal of Animal Science 2011, 89:1581-1587.
2. Allan G.M., Ellis J.A. Porcine circoviruses: A review. Journal of Veterinary Diagnostic Investigation 2000, 12:3-14.
3. Beach N.M., Meng X.J. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Research 2012, 164:33-42.
4. Blanchard P., Mahn D., Cariolet R., Keranflec'h A., Baudouard M.A., Cordioli P., Albina E., Jestin A. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) protein. Vaccine 2003, 21:4565-4575.
5. Brunborg I.M., Moldal T., Jonassen C.M. Quantitation of porcine circovirus type 2 isolated from serum/plasma and tissue samples of healthy pigs and pigs with postweaning multisystemic wasting syndrome using a TaqMan-based real-time PCR. Journal of Virological Methods 2004, 122:171-178.
6. Chae C. Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology. The Veterinary Journal 2004, 168:41-49.
7. Chae C. A review of porcine circovirus 2-associated syndromes and diseases. The Veterinary Journal 2005, 169:326-336.
8. Chae C. Porcine circovirus type 2 and its associated disease in Korea. Virus Research 2012, 164:107-113.
9. Charreyre, C., Beseme, S., Brun, A., Bublot, M., Joisel, F., Lapostolle, B., Sierra, P., Vaganay, A., 2005. Vaccination strategies for the control of circoviral diseases in pigs. In: Proceedings of the European Society for Veterinary Virology International Conference on Animal Circoviruses and Associated Diseases, Queen's University, Belfast, Northern Ireland, 11-13 September 2005, pp. 26-30.
10. Cheung A.K., Lager K.M., Kohutyuk O.I., Vincent A.L., Henry S.C., Baker R.B., Rowland R.R., Dunham A.G. Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Archives of Virology 2007, 152:1035-1044.
11. Clark, T. 1996. Pathology of the postweaning multisystemic wasting syndrome of pigs. In: First Proceedings of the Western Canadian Association of Swine Practitioners, pp. 22-25.
12. Cline G., Wilt V., Diaz E., Edler R. Efficacy of immunizing pigs against porcine circovirus type 2 at three or six weeks of age. Veterinary Record 2008, 163:737-740.
13. Darwich L., Mateus E. Immunology of porcine circovirus type 2 (PCV2). Virus Research 2012, 164:61-67.
14. Fachinger V., Bischoff R., Jedidia S.B., Saalmuller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
15. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., Meng X.J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. Journal of Virology 2004, 78:6297-6303.
16. Fort M., Fernandes L.T., Nofrarias M., Diaz I., Sibila M., Pujols J., Mateu E., Segalés J. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in Caesarean-derived, colostrum-deprived piglets. Veterinary Immunology and Immunopathology 2009, 129:101-107.
17. Fort M., Olvera A., Sibila M., Segalés J., Mateu E. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Veterinary Microbiology 2007, 125:244-255.
18. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26:1063-1071.
19. Fort M., Sibila M., Perez-Martin E., Nofrarias M., Mateu E., Segalés J. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 2009, 27:4031-4037.
20. Fraile L., Grau-Roma L., Sarasola P., Sinovas N., Nofrarias M., Lopez-Jimenez R., Lopez-Soria S., Silbila M., Segalés J. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity. Vaccine 2012, 30:1986-1992.
21. Gagnon C.A., Music N., Fontaine G., Tremblay D., Harel J. Emergence of a new type of porcine circovirus in swine (PCV): A type 1 and type 2 PCV recombinant. Veterinary Microbiology 2010, 144:18-23.
22. Grau-Roma L., Crisci E., Sibila M., Lopez-Soria S., Nofraris M., Cortey M., Fraile L., Olvera A., Segalés J. A proposal on porcine circovirus type 2 (PCV2) genotype definition and their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence. Veterinary Microbiology 2008, 128:23-35.
23. Ha Y., Lee Y.H., Ahn K.K., Kim B., Chae C. Reproduction of postweaning multisystemic wasting syndrome in pigs by prenatal porcine circovirus 2 infection and postnatal porcine parvovirus infection or immunostimulation. Veterinary Pathology 2008, 45:842-848.
24. Harms P.A., Sorden S.D., Halbur P.G., Bolin S.R., Lager K.M., Morozov I., Paul P.S. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Veterinary Pathology 2001, 38:528-539.
25. Hemann M., Beach N.M., Meng X.J., Halbur P.G., Opriessnig T. Vaccination with inactivated or live-attenuated chimeric PCV1-2 results in decreasing viremia in challenge-exposed pigs and may reduce transmission of PCV2. Veterinary Microbiology 2012, 158:180-186.
26. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., Hays M., Anderson J., Raymond R., Rowland R. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. Journal of the American Veterinary Medical Association 2008, 232:906-912.
27. Kekarainen T., McCullough K., Fort M., Fossum C., Segalés J., Allan G.M. Immune responses and vaccine-induced immunity against porcine circovirus type 2. Veterinary Immunology and Immunopathology 2010, 136:185-193.
28. Kim D., Kim C.H., Han K., Seo H.W., Oh Y., Park C., Kang I., Chae C. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2. Vaccine 2011, 29:3206-3212.
29. Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
30. Kurmann J., Sydler T., Brugnera E., Buergi E., Haessig M., Suter M., Sidler X. Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2. Clinical and Vaccine Immunology 2011, 18:1644-1649.
31. Ladekjær-Mikkelsen A.-S., Nielsen J., Stadejek T., Storgaad T., Krakowka S., Ellis J., McNeilly F., Allan G., Bøtner A. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Veterinary Microbiology 2002, 89:97-114.
32. Liu Q., Wang L., Willson P., Babiuk A. Quantitative, competitive PCR analysis of porcine circovirus DNA in serum from pigs with postweaning multisystemic wasting syndrome. Journal of Clinical Microbiology 2000, 38:3474-3477.
33. Lohse L., Botner A., Hansen A.S.L., Frederiksen T., Dupont K., Christensen C., Baekbo P., Nielsen J. Examination for a viral co-factor in postweaning multisystemic wasting syndrome (PMWS). Veterinary Microbiology 2008, 129:97-107.
34. Lyoo K., Joo H., Caldwell B., Kim H., Davies P.R., Torrison J. Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs. The Veterinary Journal 2011, 189:58-62.
35. Madson D.M., Patterson A.R., Ramamoorthy S., Pal N., Meng X.J., Opriessnig T. Effect of natural or vaccine-induced porcine circovirus type 2 (PCV2) immunity on fetal infection after artificial insemination with PCV2 spiked semen. Theriogenology 2009, 72:747-754.
36. Madson D.M., Patterson A.R., Ramamoorthy S., Pal N., Meng X.J., Opriessnig T. Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero. Clinical and Vaccine Immunology 2009, 16:830-834.
37. Madson D.M., Patterson A.R., Ramamoorthy S., Pal N., Meng X.J., Opriessnig T. Reproductive failure experimentally induced in sows via artificial insemination with semen spiked with porcine circovirus type 2 (PCV2). Veterinary Pathology 2009, 46:707-716.
38. Madson D.M., Ramamoorthy S., Kuster C., Pal N., Meng X.J., Halbur P.G., Opriessnig T. Characterization of shedding patterns of porcine circovirus types 2a and 2b in experimentally inoculated mature boars. Journal of Veterinary Diagnostic Investigation 2008, 20:725-734.
39. Madson D.M., Ramamoorthy S., Kuster C., Pal N., Meng X.J., Halbur P.G., Opriessnig T. Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars. Veterinary Research 2009, 40:10.
40. Martelli P., Ferrari L., Morganti M., Angelis D.E., Bonilauri P., Guazzetti S., Caleffi A., Borghetti P. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Veterinary Microbiology 2011, 149:339-351.
41. McIntosh K.A., Harding J.C., Parker S., Ellis J.A., Appleyard G.D. Nested polymerase chain reaction detection and duration of porcine circovirus type 2 in semen with sperm morphological analysis from naturally infected boars. Journal of Veterinary Diagnostic Investigation 2006, 18:380-384.
42. Meerts P., Misinzo G., Lefebvre D., Nielsen J., Botner A., Kristensen C.S., Nauwynck H. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Veterinary Research 2006, 2:6.
43. Meerts P., Van-Gucht S., Cox E., Vandebosch A., Nauwynck H.J. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunology 2005, 18:333-341.
44. Nawagitgul P., harms P.A., Morozov I., Thacker B.J., Sorden S.D., Lekchorensuk C., Paul P.S. Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assay for detection of antibodies to PCV. Clinical and Diagnostic Laboratory Immunology 2002, 9:33-40.
45. Olvera A., Sibila M., Calsamiglia M., Segalés J., Domingo M. Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs. Journal of Virological Methods 2004, 117:75-80.
46. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2-associated disease: Update on current terminology, clinical manifestation, pathogenesis, diagnosis, and intervention strategies. Journal of Veterinary Diagnostic Investigation 2007, 19:591-615.
47. Opriessnig T., Patterson A.R., Elsener J., Meng X.J., Halbur P.G. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2. Clinical and Vaccine Immunology 2008, 15:397-401.
48. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
49. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Ramamoorthy S., Meng X.J., Halbur P.G. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination. Veterinary Microbiology 2010, 142:177-183.
50. Opriessnig T., Madson D.M., Schalk S., Brockmeier S., Shen H.G., Beach N.M., Meng X.J., Baker R.B., Zanella E.L., Halbur P.G. Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae. Theriogenology 2011, 76:351-360.
51. Otake S., Dee S.A., Rossow K.D., Joo H.S., Deen J., Molitor T.W., Pijoan C. Transmission of porcine reproductive and respiratory syndrome virus by needles. Veterinary Record 2002, 150:114-115.
52. Park J.-S., Kim J., Ha Y., Jung K., Choi C., Lim J.-K., Kim S.-H., Chae C. Birth abnormalities in pregnant sows infected intranasally with porcine circovirus 2. Journal of Comparative Pathology 2005, 132:139-144.
53. Patterson A.R., Opriessnig T. Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2). Animal Health Research Reviews 2010, 11:217-234.
54. Patterson A.R., Ramamoorthy S., Madson D.M., Meng X.J., Halbur P.G., Opriessnig T. Shedding and infection dynamics of porcine circovirus type 2 (PCV2) after experimental infection. Veterinary Microbiology 2011, 149:91-98.
55. Pejsak Z., Podgórska K., Truszczyński M., Karbowiak P., Stadejek T. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS). Comparative Immunology Microbiology and Infectious Diseases 2010, 33:e1-e5.
56. Rosell C., Segalés J., Plana-Duran J., Balasch M., Rodriguez-Arrioja G.M., Kennedy S., Allan G.M., McNeilly F., Latimer K.S., Domingo M. Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. Journal of Comparative Pathology 1999, 120:59-78.
57. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarias M., Lopez-Soria S., Balasch M., Silbila M., Xu Z., Chu H.J., Fraile L., Plana-Duran J. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009, 27:7313-7321.
58. Segalés J., Allan G.M., Domingo M. Porcine circovirus diseases. Animal Health Research Reviews 2005, 6:119-142.
59. Seo H.W., Han K., Kim D., Oh Y., Kang I., Jang H., Chae C. Effect of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars. Clinical and Vaccine Immunology 2011, 18:1091-1996.
60. Shen H., Wang C., Madson D.M., Opriessnig T. High prevalence of porcine circovirus viremia in newborn piglets in five clinically normal swine breeding herds in North America. Preventive Veterinary Medicine 2010, 97:228-236.
61. Shen H.G., Beach N.M., Huang Y.W., Halbur P.G., Meng X.J., Opriessnig T. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 2010, 28:5960-5966.
62. Shibata I., Okuda Y., Yazawa S., Ono M., Sasaki T., Itagaki M., Nakajima N., Okabe Y., Hidejima I. PCR detection of porcine circovirus type 2 DNA in whole blood, serum, oropharyngeal swab, nasal swab, and feces from experimentally infected pigs and field cases. Journal of Veterinary Medical Science 2003, 65:405-408.
63. Timmusk S., Wallgren P., Brunborg I.M., Wikstrom F.H., Allan G., Meehan B., McMenamy M., McNeilly F., Fuxler L., Belak K., Podersoo D., Saar T., Berg M., Fossum C. Phylogenetic analysis of porcine circovirus type 2 (PCV2) pre- and post-epizootic postweaning multisystemic wasting syndrome (PMWS). Virus Genes 2008, 36:509-520.